DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Citigroup Maintains Neutral on Bio-Techne, Lowers Price Target to $225

Citigroup maintains Bio-Techne (NASDAQ:TECH) with a Neutral and lowers the price target from $235 to $225.

Benzinga · 02/05/2020 12:46

Citigroup maintains Bio-Techne (NASDAQ:TECH) with a Neutral and lowers the price target from $235 to $225.